Lupin (NSE:LUPIN) Beginning Cash Position : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Beginning Cash Position?

Lupin's Beginning Cash Position for the quarter that ended in Mar. 2025 was ₹0 Mil.

Lupin's annual Beginning Cash Position increased from Mar. 2023 (₹9,914 Mil) to Mar. 2024 (₹12,318 Mil) but then declined from Mar. 2024 (₹12,318 Mil) to Mar. 2025 (₹9,838 Mil).

Lupin Beginning Cash Position Historical Data

The historical data trend for Lupin's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Beginning Cash Position Chart

Lupin Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Beginning Cash Position

Get a 7-Day Free Trial

22,293.10

9,262.20

9,913.70

12,318.10

9,837.60

Lupin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Lupin Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Lupin Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Lupin's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Beginning Cash Position

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

Lupin Headlines

No Headlines